Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Spdr S&P Biotech Etf XBI

The investment seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of the S&P Biotechnology Select Industry Index derived from the biotechnology segment of a U. In seeking to track the performance of the S&P Biotechnology Select Industry Index (the index), the fund employs a sampling strategy. It generally invests... see more

Recent & Breaking News (ARCA:XBI)

Healthcare ETFs' Check Up Ahead of Higher Interest Rates

Benzinga.com  November 24, 2015

Equal Weighting Works For This Industry ETF

Benzinga.com  November 9, 2015

Traders Get Adventurous With Leveraged Biotech ETFs

Benzinga.com  October 28, 2015

State Street Global Advisors Announces ETF Share Splits

Business Wire September 1, 2015

ETF Watch: Oil makes a big move but Greece ETF leads improvers

Chris Parry February 2, 2015

SPDR® S&P Biotech ETF Receives Settlement Payment

Business Wire October 13, 2014

SPDR® S&P Biotech ETF Receives Settlement Payment

Business Wire August 18, 2014

Catching Hepatitis: Why Merck (MRK) Was Willing to Break the Bank for Idenix (IDIX)

Equities.com June 9, 2014

Biotech, Growth ETFs Have a Volatile Trading Day as Investors Struggle to Make Up Their Minds

Equities.com April 15, 2014

Biotechs Leads Nasdaq Below 4,000 in Third-Straight Week of Losses

Equities.com April 11, 2014

Nasdaq, DJIA, S&P Plunge Down as Investors Continue to Sell Growth Stocks

Equities.com April 10, 2014

Nasdaq, S&P, DJIA Gain on Fed Minutes

Equities.com April 9, 2014

Cellular Biomedicine Has Multiple Near-Term Catalysts

Accesswire October 3, 2013